PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

Eun Joo Shin, Chu Xuan Duong, Xuan Khanh Thi Nguyen, Guoying Bing, Jae Hyung Bach, Dae Hun Park, Keiichi Nakayama, Syed F. Ali, Anumantha G. Kanthasamy, Jean L. Cadet, Toshitaka Nabeshima, Hyoung Chun Kim

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

Original languageEnglish
Pages (from-to)39-50
Number of pages12
JournalNeurochemistry International
Volume59
Issue number1
DOIs
Publication statusPublished - 01-08-2011

Fingerprint

Methamphetamine
Tyrosine 3-Monooxygenase
Protein Kinase C
Phosphorylation
Therapeutics
Antisense Oligonucleotides
Induced Hyperthermia
Protein C Inhibitor
Protein Kinase Inhibitors
Knockout Mice
Dopamine
Pharmacology

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Shin, E. J., Duong, C. X., Nguyen, X. K. T., Bing, G., Bach, J. H., Park, D. H., ... Kim, H. C. (2011). PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment. Neurochemistry International, 59(1), 39-50. https://doi.org/10.1016/j.neuint.2011.03.022
Shin, Eun Joo ; Duong, Chu Xuan ; Nguyen, Xuan Khanh Thi ; Bing, Guoying ; Bach, Jae Hyung ; Park, Dae Hun ; Nakayama, Keiichi ; Ali, Syed F. ; Kanthasamy, Anumantha G. ; Cadet, Jean L. ; Nabeshima, Toshitaka ; Kim, Hyoung Chun. / PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment. In: Neurochemistry International. 2011 ; Vol. 59, No. 1. pp. 39-50.
@article{573f8f5b7ab94fc3be9d2d96784091ea,
title = "PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment",
abstract = "The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.",
author = "Shin, {Eun Joo} and Duong, {Chu Xuan} and Nguyen, {Xuan Khanh Thi} and Guoying Bing and Bach, {Jae Hyung} and Park, {Dae Hun} and Keiichi Nakayama and Ali, {Syed F.} and Kanthasamy, {Anumantha G.} and Cadet, {Jean L.} and Toshitaka Nabeshima and Kim, {Hyoung Chun}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.neuint.2011.03.022",
language = "English",
volume = "59",
pages = "39--50",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "1",

}

Shin, EJ, Duong, CX, Nguyen, XKT, Bing, G, Bach, JH, Park, DH, Nakayama, K, Ali, SF, Kanthasamy, AG, Cadet, JL, Nabeshima, T & Kim, HC 2011, 'PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment', Neurochemistry International, vol. 59, no. 1, pp. 39-50. https://doi.org/10.1016/j.neuint.2011.03.022

PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment. / Shin, Eun Joo; Duong, Chu Xuan; Nguyen, Xuan Khanh Thi; Bing, Guoying; Bach, Jae Hyung; Park, Dae Hun; Nakayama, Keiichi; Ali, Syed F.; Kanthasamy, Anumantha G.; Cadet, Jean L.; Nabeshima, Toshitaka; Kim, Hyoung Chun.

In: Neurochemistry International, Vol. 59, No. 1, 01.08.2011, p. 39-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PKCδ inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment

AU - Shin, Eun Joo

AU - Duong, Chu Xuan

AU - Nguyen, Xuan Khanh Thi

AU - Bing, Guoying

AU - Bach, Jae Hyung

AU - Park, Dae Hun

AU - Nakayama, Keiichi

AU - Ali, Syed F.

AU - Kanthasamy, Anumantha G.

AU - Cadet, Jean L.

AU - Nabeshima, Toshitaka

AU - Kim, Hyoung Chun

PY - 2011/8/1

Y1 - 2011/8/1

N2 - The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

AB - The present study was designed to evaluate the specific role of protein kinase C (PKC) δ in methamphetamine (MA)-induced dopaminergic toxicity. A multiple-dose administration regimen of MA significantly increases PKCδ expression, while rottlerin, a PKCδ inhibitor, significantly attenuates MA-induced hyperthermia and behavioral deficits. These behavioral effects were not significantly observed in PKCδ antisense oligonucleotide (ASO)-treated- or PKCδ knockout (-/-)-mice. There were no MA-induced significant decreases of dopamine (DA) content or tyrosine hydroxylase (TH) expression in the striatum in rottlerin-treated-, ASO-treated- or PKCδ (-/-)-mice. The administration of MA also results in a significant decrease of TH phosphorylation at ser 40, but not ser 31, while the inhibition of PKCδ consistently and significantly attenuates MA-induced reduction in the phosphorylation of TH at ser 40. Therefore, these results suggest that the MA-induced enhancement of PKCδ expression is a critical factor in the impairment of TH phosphorylation at ser 40 and that pharmacological or genetic inhibition of PKCδ may be protective against MA-induced dopaminergic neurotoxicity in vivo.

UR - http://www.scopus.com/inward/record.url?scp=79960199029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960199029&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2011.03.022

DO - 10.1016/j.neuint.2011.03.022

M3 - Article

VL - 59

SP - 39

EP - 50

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 1

ER -